Detection of single nucleotide polymorphisms (SNPs) in HER2, MUC1, ESR1, and BRCA1 genes associated with canine mammary cancer
Autor: | Juan D. Carvajal-Agudelo, Laura Giraldo-Chalarca, Diana M. Cortes-Mera, Paula A. Ossa-López, Edwin D. Morales-Álvarez, Fredy A. Rivera-Páez |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Veterinarska stanica Volume 52 Issue 5 |
ISSN: | 1849-1170 0350-7149 |
Popis: | Worldwide, canine mammary cancer (CMC) is the most frequent type of neoplasia in female dogs, and it is three times more frequent in dogs than in humans. In Colombia, CMC is the second most frequent type of cancer, after skin neoplasia. Genetics is one of the most important factors involved in any type of cancer, and the genetic basis of this disease is reflected through line breeding due to changes in allelic frequencies that are traceable using molecular markers. This study aimed to detect single nucleotide polymorphisms (SNPs) associated with CMC in blood samples collected from collected from healthy and CMC female dogs at Diego Villegas Toro Veterinary Hospital of Universidad de Caldas (Manizales, Colombia). We designed primers using Primer-BLAST and Primer3, and gene fragments from HER2, MUC1, ESR1, and BRCA1 were amplified to identify SNPs through genome mapping using the UCSC Genome Institute genome browser. We used the genome of Canis lupus familaris Boxer breed [GCF_000002285.3, (CanFam 3.1)] as a reference to compare the gene fragments and SNPs. We associated SNPs with the CMC and control groups by testing odds ratios (OR) through Fisher’s exact tests to determine an association or risk for CMC. We detected two SNPs for ESR1, three for MUC1, six for HER2, and one for BRCA1. MUC1 was the only gene to display an SNP in an exonic region that resulted in an amino acid substitution (Pro>Thr). No significant differences based on the OR were found, though the majority of SNPs, with the exception of four, were found in females with CMC. We report a novel molecular marker for HER2 that amplifies exons 25–26 and introns 24-25, and highlight the importance of conducting further studies on MUC1 and elucidating the role of introns and splicing in candidate genes associated with CMC. Diljem svijeta, tumor mliječne žlijezde kuja (CMC) najčešća je skupina neoplazija kuja te je tri puta učestalija u pasa nego u ljudi. U Kolumbiji, CMC je bio druga najčešća vrsta tumora, nakon neoplazija na koži. Nadalje, genetika je jedan od najvažnijih čimbenika uključenih u bilo koju vrstu tumora, a genetska baza ove bolesti održava se kroz linijski uzgoj uslijed promjena alelnih frekvencija, koje se mogu pratiti preko molekularnih markera. Ova studija imala je za cilj detektirati polimorfizme jednog nukleotida (SNP-e) povezane s CMC-om u uzorcima krvi prikupljenih od kuja s CMC-om i zdravih kuja u veterinarskoj bolnici Diego Villegas Toro Sveučilišta Caldas (Manizales, Kolumbija). Dizajnirali smo početnice uporabom Primer-BLAST i Primer3 te su fragmenti gena HER2, MUC1, ESR1 i BRCA1 pojačani za identifikaciju SNP-a preko mapiranja genoma uporabom preglednika genoma Instituta za genom Sveučilišta Santa Cruz u Kaliforniji (UCSC). Rabili smo genom Canis lupus familaris pasmine bokser [GCF_000002285.3, (CanFam 3.1)] kao referencu za usporedbu fragmenata gena i SNP-a. Povezali smo SNP-e s CMC-om i kontrolnim skupinama testiranjem omjera izgleda (OR) pomoću Fisherovih egzaktnih testova za određivanje povezanosti ili rizika od CMC-a. Detektirali smo dva SNP-a za ESR1, tri za MUC1, šest za HER2 i jedan za BRCA1. MUC1 je bio jedini gen koji je pokazao SNP u regiji egzona što je rezultiralo supstitucijom aminokiseline (Pro>Thr). Nismo pronašli značajne razlike na temelju OR-a, premda je većina SNP-a, izuzev četiri, pronađena u kuja s CMC-om. Prijavljujemo novi molekularni marker za HER2 koji pojačava egzone 25 - 26 i introne 24 - 25 te naglašavamo važnost provođenja dodatnih studija na MUC1, kao i pojašnjenja uloge introna i izrezivanja u gena kandidata poveznih s CMC-om. |
Databáze: | OpenAIRE |
Externí odkaz: |